vimarsana.com

Page 46 - தேசிய மனிதன் மரபணு ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NHGRI proposes an action agenda for building a diverse genomics workforce

 E-Mail The National Human Genome Research Institute (NHGRI) within the National Institutes of Health (NIH) has released a new action agenda for a diverse genomics workforce. This ambitious set of goals, objectives, and implementation strategies details NHGRI s plans for enhancing the diversity of the genomics workforce by 2030. To reach its full potential, the field of genomics requires a workforce that better reflects the diversity of the U.S. population, NHGRI Director Eric Green, M.D., Ph.D., said. Fostering an appropriately diverse genomics workforce of the future requires an immediate and substantial commitment of attention and resources. Our new action agenda aims to bring both short- and long-term changes that will make genomics a more-inclusive discipline.

Breakthrough Study Supports Genetic Editing as a Potential Treatment for Rare Rapid-Aging Disease Progeria

Share this article PEABODY, Mass., Jan. 6, 2021 /PRNewswire/  The Progeria Research Foundation (PRF) announced today the publication of a breakthrough preclinical mouse study in the journal Nature, demonstrating the substantial effect of genetic editing in directly reversing the mutation that causes Hutchinson-Gilford Progeria Syndrome (HGPS, or Progeria). Scientists at Broad Institute, the National Institutes of Health (NIH), PRF and others contributed to this ground-breaking study, indicating a critical new pathway toward correcting the root cause of Progeria. Progeria is an ultra-rare, fatal, pediatric rapid-aging disease, affecting approximately 400 children worldwide. Without the FDA-approved treatment Zokinvy (lonafarnib), children with Progeria die of heart disease at an average age of 14.5 years, due to premature atherosclerosis resulting in heart attacks. Zokinvy increases average lifespan by 2.5 years and improves some symptoms of Progeria, but it does not address

DNA-editing method shows promise to treat mouse model of progeria

 E-Mail IMAGE: Progeria is caused by a mutation in the nuclear lamin A gene in which one DNA base C is changed to a T. Researchers used the base editing method, which substitutes. view more  Credit: Ernesto del Aguila III, NHGRI Researchers have successfully used a DNA-editing technique to extend the lifespan of mice with the genetic variation associated with progeria, a rare genetic disease that causes extreme premature aging in children and can significantly shorten their life expectancy. The study was published in the journal Nature, and was a collaboration between the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health; Broad Institute of Harvard and MIT, Boston; and the Vanderbilt University Medical Center, Nashville, Tennessee.?

Congress approves a boost for CDC funding, no growth for CMS in next fiscal year

Congress approves a boost for CDC funding, no growth for CMS in next fiscal year Modern Healthcare Print Congress on Monday overwhelming approved a spending package for fiscal 2021 that includes $7.9 billion for the Centers of Disease Control and Prevention $125 million over its current budget while the budget for CMS would remain flat at $4 billion. The package also includes a roughly 3% increase in funding for the National Institutes of Health. The $1.4 trillion appropriations package would boost the NIH s budget by $1.25 billion to approximately $42.9 billion. Of that total, $6.36 billion would go to the National Cancer Institute, $3.66 billion to the National Heart, Lung, and Blood Institute, and $615.8 million to the National Human Genome Research Institute.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.